VIEW
IN BROWSER
EDITOR'S
NOTE: Big4Bio newsletters will not be
published from Dec 16, 2025 to Jan 4, 2026; they
will resume distribution on Monday, Jan 5, 2026.
|
 |
|
December 15, 2025 |
| Covering
Life Sciences Drugs, Diagnostics,
Devices, Digital Health |
|
|
|
* may need subscription to view |
- Actinium Pharmaceuticals: New Preclinical
Data Demonstrating Potent Anti-Tumor Activity
of ATNM-400 Across Multiple Breast Cancer
Subtypes Including Hormone Receptor-Positive,
Triple-Negative, and Tamoxifen- and HER2
Therapy-Resistant Breast Cancer Models at
SABCS 2025 More
- Anavex Life Sciences: Update on
Regulatory Review in the EU for Blarcamesine
to Treat Early Alzheimer’s Disease More
More*
- Merck: Receives Positive EU CHMP Opinion for
Expanded Use of WINREVAIR (sotatercept) in
Adults With Pulmonary Arterial Hypertension
(PAH, WHO* Group 1 Pulmonary Hypertension) More
|
|
- Get
Full Access to BYTE51 Life Sciences
Intelligence for 50% Off
More
- Intelligent Bio Solutions: Reverse Stock
Split More
- JPM Week Conference Readiness
Packages (Big4Bio Subscriber Discount) More
- More on Cycle Seizing Struggling
Applied TX, Picking Up Rare Disease Biotech
for Pennies per Share More
More*
- More on Impulse Dynamics Clinching $158M for
Chronic Heart Failure Implant More
- Pfizer: First-Quarter 2026 Dividend
More
- Taconic Invested $2B to Be NYC's Leading
Life Sciences Developer. Then The Market Froze
More*
|
|
- Biotech Hangout: Episode 166 Podcast
- CRISPR Streamlines Goldenberry Growth to
Enable Large-Scale Farming
More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- The Big4Bio Podcast: Every Moment
Matters: Integrating AI into Drug Discovery
Podcast
- This New, One-Two Punch Could Knock
Out Drug-Resistant TB More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: NYC Life Science Company
Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
Feature your company |
|
Apply to have your company
showcased by Big4Bio. |
|
|
|
|
|
 |
| M&A
in Life Sciences: The Turning Tide
– Why Now is a Strategic
Inflection for Biopharma and
Biotech |
|
Learn More
→ |
|
|
- Centessa CEO to Step Down; John Maraganore,
Clive Meanwell Find CMO for Their New Cardio
Bet More*
- ICYMI: CEO's Perspective: Big Moves Come
with Big Responsibilities More
- ICYMI: CEO's Perspective: The High Cost of
Job Hopping More
- ICYMI: Elevating Executive Presence: A
Blueprint for Life Sciences and Biotech
Leaders More
- ICYMI: The Power of Peer Learning: Why Even
Top Biotech Leaders Need Mentorship More
- ICYMI: What’s Next in Precision Medicine:
Leadership Challenges and Opportunities More
- 9 Companies Hiring in New Jersey More
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:NYC,
all rights reserved 2025
© 2025
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
